Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of ...
A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital ...
24/7 Wall St. on MSN
Biotech could be one of 2026’s biggest winners, and this ETF is perfectly positioned
Quick Read FBT returned 29% over the past year and gained 5.4% in the first week of 2026. Federal Reserve officials forecast ...
A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...
With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...
After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond ...
Investor's Business Daily on MSN
This biotech stock eyes fresh entry with 522% earnings growth seen
Medicine remains one of the most potentially rewarding of all investment areas. And this biotech stock is flirting with a buy ...
A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...
Explore the Latest Research Peptides from Biotech Labz Supply Sebastopol, United States – January 4, 2026 / Biotech Labz Supply / Biotech Labz Supply has revealed an exciting enhancement of its ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback